There is no single treatment that works for everyone with vitiligo. The right option depends on several considerations: how widespread is your vitiligo? Is it currently spreading or stable? Which areas of your body are affected? What is your skin type? What are your personal treatment goals?
This page gives you a clear overview of the main treatment options so you can have a more informed conversation with your doctor.
Treatment for vitiligo broadly falls into four categories: topical treatments, light-based therapies, surgical procedures, and depigmentation. Speaking to a dermatologist who specialises in vitiligo will help you identify the most appropriate starting point for your situation.
Creams and ointments are applied directly to the skin. Topical treatments for vitiligo include corticosteroids, calcineurin inhibitors, and the newer topical JAK inhibitor ruxolitinib. They are typically the first treatment tried, especially for restoring skin colour in small or localised patches. The treatments work by controlling the body’s immune response at the site of application.
Controlled exposure of the skin to ultraviolet light, typically narrowband UVB (NB-UVB). Phototherapy is one of the most widely used and well-researched treatments for vitiligo. It works by suppressing local immune activity and stimulating surviving melanin-producing cells (melanocytes) to restore lost skin colour. Phototherapy sessions are usually done two to three times per week.
Surgical treatments transplant healthy skin to depigmented areas of the body. These options are only suitable for stable vitiligo, where no new patches have appeared, and existing ones have not grown for at least 12 months. Surgeries for vitiligo treatment include skin grafting, blister grafting, and cellular melanocyte transplantation.
Depigmentation is a permanent process which removes the remaining skin colour from unaffected skin to create a uniform appearance with the surrounding patches. To remove the pigment, special creams are applied over several months. Depigmentation is considered only when vitiligo affects more than 50% of the body and when other treatments have not been effective or viable.
The table below summarises the key features of each main treatment approach. Keep in mind that the effectiveness of these treatments can vary significantly between individuals. It’s best to seek professional medical advice to determine the best course of treatment for yourself.
| Treatment | How it Works | Best For | Effectiveness | Risks/Side Effects | Time to See Results |
|---|---|---|---|---|---|
| Topical corticosteroids | Suppresses local immune activity to reduce the destruction of melanocytes | Small, localised patches, early-stage vitiligo | Moderate. Most effective on the face and neck | Skin thinning, stretch marks after prolonged use | 3-6 months |
| Topical ruxolitinib | JAK inhibitors block the signalling pathway that drives melanocyte destruction | Non-segmental vitiligo, facial patches | High effectiveness for facial repigmentation | Possible acne or itching on the application site | 3-6 months |
| Narrowband UVB phototherapy (NB-UVB) | UV light suppresses the immune response in the skin and stimulates melanocyte activity | Widespread vitiligo, for both active and stable conditions | High, known as one of the most effective treatments available | Risks related to long-term UV ray exposure | Up to 12 months |
| Skin grafting / blister grafting (Surgical) | Healthy, pigmented skin is transplanted to depigmented patches | Stable, localised vitiligo and patches that have not responded to other treatments | Effective for stable vitiligo with localised patches. Less effective for widespread conditions | Surgical scarring or infection | 2-6 months |
| Melanocyte transplantation | Melanocyte cells are harvested and transplanted to depigmented areas | Stable vitiligo, with large areas unsuitable for conventional skin grafting | High repigmentation rates in stable vitiligo | Requires specialised facilities | 3-6 months for initial results |
| Depigmentation | Chemical creams remove remaining pigment from healthy skin to create a uniform tone | Widespread vitiligo affecting more than 50% of the body, and when other treatments are not practical | Effective at creating a uniform appearance. However, does not restore the original skin pigment | Permanent and irreversible, may increase the skin’s UV sensitivity | 6-12+ months for full effect |
The answer to this question depends on how active your vitiligo is, how much of your body is affected, and how you personally wish to approach treatment. Your dermatologist will be able to recommend a personalised treatment plan based on a full assessment of your individual case.
| Mild vitiligo | Spreading vitiligo | Stable vitiligo |
|---|---|---|
|
Small number of patches, limited spread, early diagnosis.
Early treatment gives the best chance of repigmentation for this stage. |
The condition is in an active stage; new patches appear, and existing ones grow.
Spreading vitiligo requires prompt professional attention. Seek a specialist referral quickly if you notice rapid changes in your skin. |
No new patches have appeared in 6–12 months, and existing patches are not expanding.
Stable vitiligo opens the door to surgical options that can produce lasting results in the right candidate. |
Not sure which vitiligo category you fall into?
Speak to a dermatologist in Singapore for guidance on diagnosis and treatment.
One of the most important developments in vitiligo management is the growing evidence that combining treatments produces better results than using a single approach. Examples of combination vitiligo treatments include:
The most widely used combination. Phototherapy stimulates melanocytes and suppresses immune activity, while topical treatments such as tacrolimus or corticosteroids target specific areas of the skin for the same effect.
Studies show that combining NB-UVB with topical calcineurin inhibitors produces significantly better repigmentation than either treatment alone, particularly on the face and trunk.
For cases involving stable vitiligo, surgically transplanting melanocytes followed by phototherapy helps stimulate the newly transplanted cells to produce pigment. NB-UVB phototherapy typically starts four to six weeks after surgery, and is an important part of the post-surgical protocol for achieving the best results.
Choosing the right vitiligo treatment is a very personal decision that depends on your needs. What works well for one person may not work as well for another. The most important step is to seek professional guidance early and stay consistent with your vitiligo management plan.
Learn more about living with vitiligo by connecting with our support group in Singapore.
For more widespread vitiligo, narrowband UVB phototherapy combined with topical treatments is generally the fastest evidence-based approach to broader repigmentation. However, do keep in mind that “fastest” is relative, and the response rate varies significantly between individuals.
Treatment also depends heavily on the location and size of the patches treated. Areas like the face and neck typically respond faster than hands and feet. No treatment works overnight, and consistency over several months is essential regardless of which approach you use.
Narrowband UVB phototherapy is considered safe and is one of the most well-researched treatments for vitiligo. It has been used clinically for decades and is recommended for adults and children alike.
Short-term side effects can include redness, dryness, and mild itching after sessions. The main concern with long-term use is cumulative UV exposure, which is monitored by your dermatologist through careful dosing. If you have any concerns about phototherapy, do discuss your full medical history with your dermatologist, including any personal or family history of skin cancer.
Yes, vitiligo can return after treatment. This is one of the key challenges in long-term management.
Research indicates that almost 50% of vitiligo lesions recur in the first year after repigmentation without maintenance therapy. This is why many dermatologists recommend a maintenance approach after repigmentation is achieved. For example, applying tacrolimus twice weekly to the area greatly reduces the risk of relapse.
The likelihood of vitiligo recurrence varies by treatment type and individual. Ongoing sun protection, stress management, and avoiding known personal triggers can also help reduce the risk of vitiligo returning.
